Nuveen Taxable Municipal Income Fund Common Shares of Beneficial Interest (NBB)
StalwartFairStock Score: 24/100 — RISKY
Key Financials
| Current Price | $15.6 |
| Market Cap | $465M |
| P/E Ratio | 16.6 |
| ROE | —% |
| Dividend Yield | 7.39% |
| Sector | Financial Services |
Strengths
- Attractive 7.3% dividend yield providing steady income returns
Concerns
- Elevated P/E of 43.3x prices in substantial future growth that may not materialize
- Weak Piotroski F-Score of 1/9 suggests deteriorating financial quality across multiple dimensions
- Altman Z-Score of 1.1 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Nuveen Taxable Municipal Income Fund Common Shares of Beneficial Interest is a micro-cap financial services company valued at $465 million. From a quality standpoint, Nuveen shows weak Piotroski F-Score of 1/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 1.1 warrants caution. On valuation, the stock is commanding a steep 43.3x multiple, with trades above its Graham Number with a negative 37% margin. The 7.3% dividend yield adds an income component for patient holders. Our composite FairStock Score of 24/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
At 43x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer